|

Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer

RECRUITINGSponsored by Rambam Health Care Campus
Actively Recruiting
SponsorRambam Health Care Campus
Started2023-07-26
Est. completion2026-08-01
Eligibility
Age18 Years – 85 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06196190

Summary

In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma, Adeno-squamous carcinoma or AIS we want to examine prospectively: 1. Examine if negative HR-HPV after conization to the HR-HPV the women had before conization has a high prognostic value for no residual tumor in the final pathology. 2. To examine if conization in women with cervical tumor up to Stage I B 2 (FIGO 2018) is corelated with better prognosis.

Eligibility

Age: 18 Years – 85 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

Age Range: 18-85 years old Cervical cancer stage I B 2(Tumor up to 4 cm FIGO 2018) AIS HPV types before and after conization

Exclusion Criteria:

Pregnant women under 18 years old. Women who refused to continue to be in study. Women that data about HPV types , final pathology or complication are missing.

Conditions3

CancerCervix CancerHPV-Related Malignancy

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.